📖 Approx. 11 min ／ Updated 05.07.2026
The dissolution of a medical corporation signifies the end of its business operations and is a crucial management decision. Unlike M&A or business succession, the dissolution process involves a wide range of procedures, and particularly the distribution of residual assets presents complex issues unique to medical corporations. This article explains the practical procedures from dissolution to the completion of liquidation for medical corporations, differences in residual asset distribution based on the presence or absence of equity stakes, and tax considerations, while also comparing these with M&A and business succession.
Legal Basis and Types of Medical Corporation Dissolution, and Comparison with M&A
The dissolution of a medical corporation is carried out based on the provisions of the Medical Care Act and the Civil Code. The main grounds for dissolution include voluntary dissolution by resolution of the general meeting of members, dissolution due to merger, dissolution through bankruptcy proceedings, and dissolution by order of the administrative agency. Among these, voluntary dissolution, which proceeds based on a voluntary decision, may be chosen for various reasons such as the absence of a successor, retirement of management, or changes in the business environment.
There are three main types of medical corporations: “medical corporations with equity stakes,” “medical corporations without equity stakes (such as specific medical corporations, social medical corporations, and general incorporated association types),” and “fund contribution type medical corporations.” The handling of residual assets upon dissolution differs significantly for each type. Medical corporations with equity stakes are characterized by the repayment of stakes to shareholders, but new establishments have not been permitted since the amendment of the Medical Care Act in 2007. For medical corporations without equity stakes, residual assets generally revert to the national treasury or similar organizations. Fund contribution type corporations have an obligation to return the funds.
When it becomes difficult for a medical corporation to continue its business, options other than dissolution, such as M&A or business succession, also exist. M&A and business succession involve transferring the business to a third party, thereby continuing contributions to regional healthcare while providing the management with an opportunity to receive transfer consideration. On the other hand, dissolution means terminating the business itself, so important aspects to consider include maintaining employee employment, the impact on patients, and the impact on the regional healthcare provision system. The optimal choice depends greatly on the type of corporation, its financial status, its role in regional healthcare, and the intentions of the management.
Key Procedural Steps from Dissolution to Completion of Liquidation of a Medical Corporation
The process from the dissolution of a medical corporation to the completion of liquidation generally involves the following steps. While the specifics of these procedures may vary depending on the corporation’s situation and the prefecture, understanding the general flow is important.
- Resolution for Dissolution and Appointment of Liquidator
A resolution for dissolution is made at the general meeting of members (for medical corporations by association) or the board of directors (for medical corporations by foundation). Simultaneously, a liquidator is appointed, who will manage the corporation’s affairs after dissolution.
- Notification to Administrative Agency and Registration Application
After the resolution for dissolution, prompt notification is made to the governor of the relevant prefecture (or the Minister of Health, Labour and Welfare). Additionally, applications for registration of dissolution and appointment of liquidator are filed with the Legal Affairs Bureau.
- Creditor Protection Procedures (Official Gazette Announcement and Individual Notification)
The fact of dissolution is announced in the Official Gazette, and creditors are requested to submit claims within a period of two months or more. Individual notification is required for known creditors.
- Preparation and Approval of Inventory of Assets and Balance Sheet
The liquidator prepares an inventory of assets and a balance sheet to clarify the financial status at the time of dissolution, and obtains approval from the general meeting of members, etc.
- Payment of Debts and Liquidation of Assets
The liquidator repays debts in response to claims from creditors. If there is insufficient cash, assets such as medical equipment, real estate, and securities are liquidated (sold) to secure funds.
- Determination and Distribution of Residual Assets
After all debts have been paid, the remaining assets become residual assets. These are distributed according to the type of corporation. For medical corporations with equity stakes, they are distributed to shareholders; for medical corporations without equity stakes, they revert to the national treasury, etc.
- Liquidation Report and Registration of Completion of Liquidation
Once all liquidation affairs are completed, the liquidator prepares a liquidation report and obtains approval from the general meeting of members. Subsequently, an application for registration of completion of liquidation is filed with the Legal Affairs Bureau, and the legal personality of the corporation is extinguished.
These procedures require specialized knowledge, so it is common to proceed in collaboration with professionals such as lawyers, tax accountants, and judicial scriveners. In particular, neglecting creditor protection procedures can lead to personal liability for the liquidator, so utmost care is necessary.
Specifics of Residual Asset Distribution in Medical Corporations with Equity Stakes
The distribution of residual assets upon the dissolution of a medical corporation with equity stakes involves particularly complex issues compared to other types of corporations. This type of medical corporation has stakes held by shareholders based on their contributed capital, and upon dissolution, they have the right to receive repayment of residual assets corresponding to these stakes.
To determine the amount of residual assets to be distributed, it is first necessary to value all assets and liabilities of the corporation and calculate the net asset value. The assets of a medical corporation include real estate (land and buildings), medical equipment, pharmaceutical inventory, deposits, etc., and these must be valued at their market value. In particular, medical equipment and real estate have significant fluctuations in market value, and their valuation greatly affects the residual assets.
The repayment of equity stakes may be treated as a “deemed dividend” for tax purposes. This means that income tax may be levied on the portion of the repayment exceeding the amount of contributed capital. For example, if the contributed capital was 10 million yen and the repayment upon dissolution was 30 million yen, the difference of 20 million yen may be considered a deemed dividend and become subject to taxation as dividend income. This tax treatment is highly specialized, and it is essential to consult thoroughly with a tax accountant in advance and take appropriate measures.
Furthermore, while equity stakes are rights held by members, issues such as changes in membership or inheritance may arise upon dissolution. In the past, court precedents have upheld the validity of articles of incorporation stipulating the waiver of equity stakes upon the death of a member, but the interpretation varies depending on the specific content of the articles of incorporation and the circumstances. With the advancement of regional healthcare plans, in cases of dissolution involving a reduction in hospital beds, there may be a system in place for providing certain compensation. If such compensation is included in the residual assets, its tax treatment must also be carefully considered. The dissolution of a medical corporation with equity stakes involves significant financial transactions and associated tax risks, making meticulous simulation and planning by experts indispensable.
Residual Asset Distribution for Medical Corporations Without Equity Stakes and Fund Contribution Type Medical Corporations
Medical corporations established on or after April 1, 2007, are generally established as “medical corporations without equity stakes” that do not have equity stakes. When this type of medical corporation dissolves, the distribution of residual assets differs significantly from that of medical corporations with equity stakes.
For medical corporations without equity stakes, residual assets are generally attributed to the national government, local public entities, or other public-interest corporations with similar objectives, such as other medical corporations or social welfare corporations, in accordance with the provisions of the articles of incorporation. Distribution to specific individuals or organizations is generally not permitted. This is a measure to prevent the privatization of assets of medical corporations, which are public-interest entities.
On the other hand, “fund contribution type medical corporations” do not have equity stakes but receive contributions of money, etc., as “funds” at the time of establishment or during operation, and bear the obligation to return these funds. Funds serve as the source for forming the corporation’s assets but, unlike equity, do not represent members’ stakes. Upon dissolution, after all debts have been paid, the funds are returned to the fund contributors from the residual assets. However, the repayment amount is capped at the contributed amount, and depending on the corporation’s financial situation, full repayment may not be possible. The tax treatment of fund returns differs from that of equity stake repayments, so this point also needs to be confirmed with an expert.
“Specific medical corporations” and “social medical corporations” that meet certain requirements receive preferential tax treatment, but their dissolution is subject to even stricter residual asset attribution regulations. As these corporations aim for highly public-interest activities, their residual assets must revert to the national treasury or similar public-interest corporations, and private distribution is strictly prohibited.
| Type of Medical Corporation | Distribution of Residual Assets (Principle) | Tax Considerations | Approximate Establishment Period |
|---|---|---|---|
| Medical Corporation with Equity Stakes | Distributed to shareholders (members) according to their equity stakes | Possibility of deemed dividend taxation | Before March 31, 2007 |
| Medical Corporation Without Equity Stakes | National government, local public entities, public-interest corporations with similar objectives | Generally no corporate tax (due to public interest purpose) | On or after April 1, 2007 |
| Fund Contribution Type Medical Corporation | Return of funds to fund contributors (with limits) | Confirm tax treatment regarding fund returns | On or after April 1, 2007 |
Tax Issues and Considerations Associated with Dissolution
The dissolution of a medical corporation has wide-ranging tax implications, including corporate tax, consumption tax, and business tax. During the liquidation period, different reporting and tax payment procedures are required compared to regular business periods, making collaboration with experts essential.
First, the calculation of corporate tax for the dissolution business year and the liquidation period differs from that of regular business periods. In particular, gains from the liquidation of assets or income from the discharge of debt may be included in taxable income. For consumption tax, complex procedures may be required for the sale of assets upon dissolution and adjustments for consumption tax on unpaid purchases. Business tax is also levied on the income of the liquidation period, so it is necessary to understand its calculation method.
If the business form changes from a medical corporation to a sole proprietorship, a notification of business commencement as a sole proprietor is required concurrently with the dissolution of the corporation, and capital gains tax may be incurred on the transfer of assets and unrealized gains during that period. For example, if a sole proprietor takes over medical equipment owned by the corporation, it may be deemed a capital gain based on its market value and become subject to taxation.
Furthermore, trends in medical fee revisions directly affect the profitability of medical institutions and are an important factor when considering dissolution. If a major medical fee revision is planned around the time dissolution is being considered, it is necessary to consider how it will affect asset values and future earnings projections. The handling of licenses and permits is also important. Upon the dissolution of a medical corporation, the establishment permit and approvals for various facility standards become invalid. Procedures for their proper return or abolition are necessary. In particular, for licenses and permits requiring specialized knowledge, such as narcotic administrator licenses and permits for the installation of specific medical equipment, it is important to confirm their handling in advance.
【Important】Tax Points to Note Upon Dissolution
Due to its unique nature, the dissolution of a medical corporation involves complex interactions between multiple tax categories, including corporate tax, consumption tax, and income tax (deemed dividends, etc.). In particular, taxation related to asset valuation, residual asset distribution, and asset transfers to individuals carries the risk of unforeseen tax burdens if not handled with specialized knowledge.
✅ Corporate tax filing for the liquidation period
✅ Market valuation of assets and capital gains tax
✅ “Deemed dividend” taxation for corporations with equity stakes
✅ Final consumption tax filing and refunds/payments
✅ Calculation of business tax for the liquidation period
It is essential to collaborate closely with specialists such as tax accountants and certified public accountants and conduct detailed simulations in advance for these procedures.
Comparison with M&A and Business Succession: Decision Criteria for Choosing Dissolution
When bringing an end to the operations of a medical corporation, dissolution is one option, but its advantages and disadvantages must be carefully considered in comparison with M&A and business succession.
The main advantage of dissolution is that the management is completely freed from the business, and troublesome handover procedures are unnecessary. Also, when a desired buyer cannot be found in M&A, or when there is a desire to avoid the risk of prolonged negotiations, dissolution may become a practical option. However, there are also many disadvantages. Dissolution means the extinction of the business itself, leading to the loss of brand and regional trust built over many years. Employee employment is not maintained, and patients will need to find new medical institutions. Furthermore, the liquidation process is very cumbersome and incurs professional fees. Especially for medical corporations with equity stakes, the expected net proceeds may decrease due to deemed dividend taxation on the distribution of residual assets.
On the other hand, choosing M&A or business succession offers the significant advantage of continuing contributions to regional healthcare by maintaining the business, and it is easier to maintain employee employment. Management can obtain a lump sum of funds as transfer consideration, which can be useful for post-retirement financial planning. For the acquiring party, taking over an existing medical institution allows them to get the business on track more quickly compared to starting a new practice.
The final decision is heavily influenced by the medical corporation’s financial situation, the presence of a successor, its role in regional healthcare, and the management’s own life plan. For example, in cases with significant debt and a capital deficit, it may be difficult to find a buyer for M&A, and dissolution may be the only option. Conversely, for medical institutions that maintain sound management and have strong regional trust, better terms for succession can be expected through M&A or business succession. MA Medical not only handles consultations regarding the dissolution of medical corporations but also comprehensively considers and proposes the optimal method for your institution from a wide range of options, including business succession and M&A.
The dissolution of a medical corporation is a major decision for management, and its procedures are complex and varied. It is difficult to proceed without specialized knowledge, such as the fundamental differences in residual asset distribution based on the presence or absence of equity stakes and the associated tax considerations. At MA Medical, experts with extensive knowledge and experience specializing in the medical industry will carefully listen to your institution’s situation and answer your questions and concerns regarding dissolution procedures. Furthermore, if you are considering M&A or business succession as alternatives to dissolution, we will compare the advantages and disadvantages of each and propose the optimal path. Please feel free to consult with us first.
For consultations on medical succession, contact MA Medical
MA Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the successful transfer of clinics and medical corporations facing successor shortages, as well as strategic acquisitions, on a success-fee basis.
- Initial consultation and preliminary assessment are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeds under NDA agreement)
- Services available nationwide in all 47 prefectures and for all medical specialties
Please consult with us early in the consideration phase, whether you just want to know the market value, have no successor, or are considering joining a group.
Frequently Asked Questions
How long does the dissolution procedure for a medical corporation generally take?
The dissolution procedure for a medical corporation, from the appointment of a liquidator to the registration of completion of liquidation, generally takes several months to over a year. It includes numerous processes such as creditor protection procedures, determination of residual assets, and tax filings, and tends to be prolonged in some cases. The duration can vary significantly depending on factors such as the existence of uncollected receivables, the scale of assets, and the coordination status with relevant organizations.
Who receives the residual assets of a dissolved medical corporation, how are they distributed, and what taxes apply?
Residual assets of a medical corporation are first used to pay off debts, and then, in accordance with the articles of incorporation and resolutions of the general meeting of members, they are generally attributed to members, the national government, local public entities, or specific public-interest corporations. Depending on the recipient, taxes such as deemed dividend tax, gift tax, or inheritance tax may apply. Tax implications vary greatly depending on individual circumstances, so it is recommended to consult with experts such as tax accountants in advance and plan carefully.
What are the differences between the dissolution of a medical corporation and M&A/business succession, and what are the criteria for deciding which to choose?
Dissolution is a procedure to extinguish the corporate personality, and there is no continuity of business. On the other hand, M&A and business succession are options to transfer management rights and business to a third party while maintaining the corporate personality. Criteria for decision include the intention to continue the business, maintenance of employee employment, impact on patients, tax advantages/disadvantages regarding residual asset distribution, and the complexity and cost of the procedures. It is common to make a decision after comprehensively considering factors such as the value of the business, the presence of a successor, and post-succession risks, in consultation with experts.